Suchergebnisse - "Weinreich, David M"

PubPharm (91)

1

Garetosmab, an inhibitor of activin A, reduces heterotopic ossification and flare-ups in adults with fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial

enthalten in: bioRxiv.org | 2023

von Di Rocco, M. | Forleo-Neto, E. | Pignolo, R. | +33

2

Garetosmab in fibrodysplasia ossificans progressiva : a randomized, double-blind, placebo-controlled phase 2 trial

enthalten in: Nature medicine | 2023

von Di Rocco, M. | Forleo-Neto, E. | Pignolo, R. | +33

3

Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles

enthalten in: Scientific reports | 2023

von Li, D. | Xu, M. | Hooper, A. | +9

4

Dupilumab in patients with prurigo nodularis : two randomized, double-blind, placebo-controlled phase 3 trials

enthalten in: Nature medicine | 2023

von Yosipovitch, G. | Mollanazar, N. | Ständer, S. | +14

5

Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019 : A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial

enthalten in: Open forum infectious diseases | 2023

von Somersan-Karakaya, S. | Mylonakis, E. | Mou, J. | +14

6

REGN1908/1909 prevented cat allergen-induced early asthmatic responses in an environmental exposure unit

enthalten in: The Journal of allergy and clinical immunology | 2022

von de Blay, F. | Gherasim, A. | Domis, N. | +15

7

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

enthalten in: bioRxiv.org | 2022

von Horby, P. | Mafham, M. | Peto, L. | +31

8

Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19

enthalten in: The Journal of infectious diseases | 2022

von Somersan-Karakaya, S. | Mylonakis, E. | Menon, V. | +31

9

Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies

enthalten in: mBio | 2022

von Hooper, A. | Somersan-Karakaya, S. | McCarthy, S. | +12

10

Real-world effectiveness of casirivimab and imdevimab among patients diagnosed with COVID-19 in the ambulatory setting : a retrospective cohort study using a large claims database

enthalten in: BMJ open | 2022

von Hussein, M. | Wei, W. | Mastey, V. | +6

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]